XML 67 R53.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 12, 2024
Aug. 01, 2023
Aug. 31, 2023
Feb. 28, 2023
Jul. 31, 2022
Apr. 30, 2022
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Apr. 04, 2022
Apr. 30, 2020
Cash consideration   $ 16,792,037                        
Options to acquire shares           144,191              
Weighted exercise price           $ 10.71                
Warrants to purchase shares           4,424                
Exercise price           $ 7.32                
Payment of contingent consideration   893,000                        
Cash     $ 693,000       $ 3,000,000.0     $ 3,000,000.0        
Cash consideration         $ 10,000,000.0                  
Number of shares         486,145                  
Earnout payment     $ 693,000                      
Number of shares issued, value                 $ 1,033,761          
Number of award shares 1,000,000                          
Stock granted and issued                   167,956        
Restricted stock award, gross                   $ 5,894,731        
Share-based compensation             1,082,750 $ 1,127,332   2,214,931 $ 1,724,637      
Unrecognized share-based compensation expense             6,557,465     6,557,465        
Selling, General and Administrative Expenses [Member]                            
Share-based compensation             $ 1,411,545 $ 1,127,332   $ 2,214,930 $ 1,724,637      
Cash Closing Consideration [Member]                            
Payments to acquire assets   $ 15,250,000                        
Stock issued during period shares issued for services   73,809                        
Purchase Agreement [Member]                            
Issuance of common stock in equity offering, shares         94,798                  
Payments to acquire assets         $ 7,600,000                  
Cash         $ 1,600,000                  
Issuance of common stock for purchase of assets         291,686                  
Common Stock [Member]                            
Issuance of common stock in equity offering, shares                 26,143          
Warrants to purchase shares           12,301                
Exercise price           $ 12.05                
Number of shares issued, value                 $ 26          
Common Stock [Member] | Sales Agreement [Member]                            
Issuance of common stock in equity offering, shares                       26,143    
Number of shares issued, value                       $ 1,100,000    
Net proceeds                       $ 900,000    
Precision Healing [Member]                            
Payment in cash           $ 600,000                
Share price           $ 27.13               $ 27.13
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member]                            
Percentage of commissions payable to sales agent       3.00%                    
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member] | Maximum [Member]                            
Sale of stock, consideration received on transaction       $ 75,000,000                    
Accredited Investors [Member]                            
Accredited investors shares           165,738                
Nonaccredited Investors [Member]                            
Share price                         $ 30.75  
Precision Healing Inc [Member]                            
Cash consideration           $ 125,966                
Payment of contingent consideration           $ 10,000,000.0                
Restated 2014 Omnibus Long Term Incentive Plan [Member]                            
Number of shares available for issuance             1,251,547     1,251,547        
Restated 2014 Omnibus Long Term Incentive Plan [Member] | Directors Officers Employees [Member]                            
Issuance of common stock in equity offering, shares                   748,453